GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent BioSolutions Inc (FRA:ER4) » Definitions » Inventories, Finished Goods

Emergent BioSolutions (FRA:ER4) Inventories, Finished Goods : €123.7 Mil (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Emergent BioSolutions Inventories, Finished Goods?

Emergent BioSolutions's quarterly finished goods increased from Jun. 2024 (€77.9 Mil) to Sep. 2024 (€110.2 Mil) and increased from Sep. 2024 (€110.2 Mil) to Dec. 2024 (€123.7 Mil).

Emergent BioSolutions's annual finished goods declined from Dec. 2022 (€87.0 Mil) to Dec. 2023 (€79.7 Mil) but then increased from Dec. 2023 (€79.7 Mil) to Dec. 2024 (€123.7 Mil).


Emergent BioSolutions Inventories, Finished Goods Historical Data

The historical data trend for Emergent BioSolutions's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent BioSolutions Inventories, Finished Goods Chart

Emergent BioSolutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.09 31.77 87.04 79.69 123.67

Emergent BioSolutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.69 70.47 77.85 110.19 123.67

Emergent BioSolutions Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Emergent BioSolutions Business Description

Traded in Other Exchanges
Address
300 Professional Drive, Gaithersburg, MD, USA, 20879
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Emergent BioSolutions Headlines

No Headlines